GLASS: Global Lorlatinib for ALK(+) and ROS1(+) Retrospective Study: Real World Data of 123 NSCLC Patients

Peled N., Gillis R., Kilickap S., Froesch P., Orlov S., Filippova E., ...More

JOURNAL OF THORACIC ONCOLOGY, vol.16, no.3, 2021 (SCI-Expanded)

• Publication Type: Article / Abstract
• Volume: 16 Issue: 3
• Publication Date: 2021
• Journal Name: JOURNAL OF THORACIC ONCOLOGY
• Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus, CINAHL, EMBASE, MEDLINE
• Keywords: ROS1(+), ALK(+), lorlatinib
• Akdeniz University Affiliated: Yes